Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
29.5%
% of RSPH's 61 holdings also in WDNA
20.5%
% of WDNA's 91 holdings also in RSPH
Overlap by Weight
Sector Drift (RSPH minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in RSPH |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 1.6% | 1.6% | 1.6% |
|
ELI LILLY & CO | 1.5% | 2.1% | 1.5% |
|
DANAHER CORP | 1.5% | 1.4% | 1.4% |
|
AMGEN INC | 1.4% | 1.4% | 1.4% |
|
CATALENT INC | 1.8% | 1.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
RSPH Overweight Relative to WDNA
|
WATERS CORP | 2.0% |
|
INSULET CORP | 2.0% |
|
MCKESSON CORP | 1.9% |
|
DEXCOM INC | 1.9% |
|
INTUITIVE SURGICAL INC | 1.9% |
|
WEST PHARMACEUTICAL SERVICES | 1.9% |
|
HENRY SCHEIN INC | 1.9% |
|
VIATRIS, INC. | 1.9% |
|
BOSTON SCIENTIFIC CORP | 1.9% |
|
INCYTE CORP | 1.9% |
RSPH Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -4.3% |
 |
NOVOZYMES A/S-B SHARES | -2.7% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
GERON CORP | -2.5% |
|
AGIOS PHARMACEUTICALS INC | -2.4% |
|
FATE THERAPEUTICS INC | -2.2% |
|
NATERA INC | -2.2% |
|
VERICEL CORPORATION | -2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.7% |
|
SAREPTA THERAPEUTICS INC | -1.7% |